COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 108 filers reported holding COHERUS BIOSCIENCES INC in Q2 2017. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $541,786 | +31.5% | 144,863 | +50.1% | 0.00% | – |
Q2 2023 | $412,070 | -69.3% | 96,504 | -50.8% | 0.00% | – |
Q1 2023 | $1,341,112 | +144.0% | 196,070 | +182.5% | 0.00% | – |
Q4 2022 | $549,653 | -17.5% | 69,401 | +0.0% | 0.00% | – |
Q3 2022 | $666,000 | +212.7% | 69,378 | +136.6% | 0.00% | – |
Q2 2022 | $213,000 | -74.3% | 29,329 | -54.3% | 0.00% | – |
Q1 2022 | $829,000 | +353.0% | 64,184 | +458.0% | 0.00% | – |
Q4 2021 | $183,000 | -82.2% | 11,503 | -82.1% | 0.00% | – |
Q3 2021 | $1,030,000 | +14.2% | 64,133 | -1.7% | 0.00% | – |
Q2 2021 | $902,000 | -9.4% | 65,266 | -4.2% | 0.00% | – |
Q1 2021 | $996,000 | -91.8% | 68,144 | -90.2% | 0.00% | -100.0% |
Q4 2020 | $12,111,000 | -25.7% | 696,792 | -21.6% | 0.00% | -50.0% |
Q3 2020 | $16,308,000 | -16.8% | 889,223 | -18.9% | 0.00% | 0.0% |
Q2 2020 | $19,591,000 | +21.4% | 1,096,990 | +10.3% | 0.00% | 0.0% |
Q1 2020 | $16,138,000 | -5.7% | 994,939 | +4.6% | 0.00% | 0.0% |
Q4 2019 | $17,119,000 | -74.2% | 950,801 | -71.0% | 0.00% | -75.0% |
Q3 2019 | $66,314,000 | -11.0% | 3,273,162 | -2.9% | 0.01% | -11.1% |
Q2 2019 | $74,533,000 | +32.4% | 3,372,527 | -18.3% | 0.01% | +28.6% |
Q1 2019 | $56,297,000 | +35.8% | 4,127,334 | -9.9% | 0.01% | +16.7% |
Q4 2018 | $41,451,000 | -61.1% | 4,580,230 | -29.1% | 0.01% | -50.0% |
Q3 2018 | $106,621,000 | +10.5% | 6,461,844 | -6.3% | 0.01% | +9.1% |
Q2 2018 | $96,533,000 | +16.7% | 6,895,214 | -7.9% | 0.01% | +10.0% |
Q1 2018 | $82,733,000 | +40.7% | 7,487,137 | +12.0% | 0.01% | +42.9% |
Q4 2017 | $58,820,000 | -42.8% | 6,684,166 | -13.3% | 0.01% | -41.7% |
Q3 2017 | $102,880,000 | -6.8% | 7,706,310 | +0.2% | 0.01% | -14.3% |
Q2 2017 | $110,396,000 | -32.0% | 7,693,124 | +0.3% | 0.01% | -33.3% |
Q1 2017 | $162,262,000 | -12.0% | 7,671,981 | +17.2% | 0.02% | -16.0% |
Q4 2016 | $184,321,000 | +5.8% | 6,547,818 | +0.6% | 0.02% | +8.7% |
Q3 2016 | $174,259,000 | +61.3% | 6,507,031 | +1.7% | 0.02% | +53.3% |
Q2 2016 | $108,032,000 | -13.2% | 6,396,228 | +9.0% | 0.02% | -11.8% |
Q1 2016 | $124,524,000 | +6.5% | 5,865,513 | +15.2% | 0.02% | +6.2% |
Q4 2015 | $116,885,000 | +55.4% | 5,090,805 | +35.6% | 0.02% | +45.5% |
Q3 2015 | $75,236,000 | -3.9% | 3,754,306 | +38.6% | 0.01% | +10.0% |
Q2 2015 | $78,262,000 | +206.5% | 2,708,029 | +224.3% | 0.01% | +233.3% |
Q1 2015 | $25,533,000 | +47.5% | 834,953 | -29.6% | 0.00% | +50.0% |
Q4 2014 | $17,311,000 | – | 1,186,853 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |